Up a level |
Mellors, Jack, Tipton, Tom, Fehling, Sarah Katharina, Akoi Bore, Joseph, Koundouno, Fara Raymond, Hall, Yper, Hudson, Jacob, Alexander, Frances, Longet, Stephanie, Taylor, Stephen et al (show 6 more authors)
(2022)
Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.
Frontiers in Immunology, 13.
857481-.
Konde, Mandy Kader, Baker, Darren P, Traore, Fode Amara, Sow, Mamadou Saliou, Camara, Alioune, Barry, Alpha Amadou, Mara, Doussou, Barry, Abdoulaye, Cone, Moussa, Kaba, Ibrahima et al (show 6 more authors)
(2017)
Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial.
PLoS One, 12 (2).
e0169255-e0169255.
Steeds, Kimberley, Hall, Yper, Slack, Gillian S, Longet, Stephanie, Strecker, Thomas, Fehling, Sarah Katharina, Wright, Edward, Bore, Joseph Akoi, Koundouno, Fara Raymond, Konde, Mandy Kader et al (show 4 more authors)
(2020)
Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies.
SCIENTIFIC REPORTS, 10 (1).
14289-.